Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Shares of Beneficial Interest, $0.001 par value per share
-
Shares outstanding
-
223,280,618
-
Number of holders
-
371
-
Total 13F shares, excl. options
-
76,814,075
-
Shares change
-
+8,945,221
-
Total reported value, excl. options
-
$2,483,087,730
-
Value change
-
+$293,139,465
-
Put/Call ratio
-
79%
-
Number of buys
-
217
-
Number of sells
-
-111
-
Price
-
$32.31
Significant Holders of Blackstone Secured Lending Fund - Common Shares of Beneficial Interest, $0.001 par value per share (BXSL) as of Q4 2024
417 filings reported holding BXSL - Blackstone Secured Lending Fund - Common Shares of Beneficial Interest, $0.001 par value per share as of Q4 2024.
Blackstone Secured Lending Fund - Common Shares of Beneficial Interest, $0.001 par value per share (BXSL) has 371 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 76,814,075 shares
of 223,280,618 outstanding shares and own 34% of the company stock.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (6,682,928 shares), MORGAN STANLEY (6,582,792 shares), VAN ECK ASSOCIATES CORP (5,563,231 shares), Ensign Peak Advisors, Inc (4,953,039 shares), NOMURA ASSET MANAGEMENT CO LTD (4,122,613 shares), Blackstone Inc. (3,206,530 shares), Northeast Financial Consultants Inc (2,361,294 shares), CCLA Investment Management (2,085,597 shares), Creative Planning (1,636,696 shares), and Royal Bank of Canada (1,533,485 shares).
This table shows the top 371 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.